title: Japanese Guideline for Childhood Asthma 2014.
abstract: The Japanese Guideline for the Diagnosis and Treatment of Allergic Diseases 2013 (JAGL 2013) describes childhood asthma after the Japanese Pediatric Guideline for the Treatment and Management of Asthma 2012 (JPGL 2012) by the Japanese Society of Pediatric Allergy and Clinical Immunology. JAGL 2013 provides information on diagnosis by age group from infancy to puberty (0-15 years of age), treatment for acute exacerbations, long-term management by anti-inflammatory drugs, daily life guidance, and patient education to allow non-specialist physicians to refer to this guideline for routine medical treatment. JAGL differs from the Global Initiative for Asthma Guideline (GINA) in that JAGL emphasizes early diagnosis and intervention at <2 years and 2-5 years of age. A management method, including step-up or step-down of long-term management drugs based on the status of asthma control levels, as in JAGL, is easy to understand, and thus the Guideline is suitable as a frame of reference for routine medical treatment. JAGL has also introduced treatment and management using a control test on children, recommending that the physician aim at complete control by avoiding exacerbation factors and by appropriate use of anti-inflammatory drugs.
authors.affiliation: Department of Pediatrics, Faculty of Medicine, Saga University, Saga, Japan.
authors.forename: Yuhei
authors.initials: Y
authors.lastname: Hamasaki
authors.affiliation: Chiba Rosai Hospital, Chiba, Japan.
authors.forename: Yoichi
authors.initials: Y
authors.lastname: Kohno
authors.affiliation: Department of Allergy, Clinical Research Center for Allergology and Rheumatology, National Hospital Organization, Sagamihara National Hospital, Kanagawa, Japan.
authors.forename: Motohiro
authors.initials: M
authors.lastname: Ebisawa
authors.affiliation: Department of Pediatrics, Graduate School of Medicine, Gifu University, Gifu, Japan.
authors.forename: Naomi
authors.initials: N
authors.lastname: Kondo
authors.affiliation: National Hospital Organization, Fukuoka National Hospital, Fukuoka, Japan.
authors.forename: Sankei
authors.initials: S
authors.lastname: Nishima
authors.affiliation: National Hospital Organization, Shimoshizu National Hospital, Chiba, Japan.
authors.forename: Toshiyuki
authors.initials: T
authors.lastname: Nishimuta
authors.affiliation: Kita Kanto Allergy Institute, Gunma, Japan.
authors.forename: Akihiro
authors.initials: A
authors.lastname: Morikawa
mesh_terms: D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001249:Asthma / Q000175:diagnosis / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D018450:Disease Progression; D042241:Early Diagnosis; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007564:Japan; D010353:Patient Education as Topic; D013997:Time Factors
chemical_list: D000893:Anti-Inflammatory Agents